WebDescription. Operator of a biotechnology company intended to develop drugs for the treatment of chronic diseases. The company's platform utilizes mass spectrometry and … WebDunad Therapeutics Pioneering Tuneable Small-Molecule Degradation PlatformDunad Therapeutics is focusing on the development of next-generation targeted protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tuneable mono-valent small molecules, unlocking new target space …
THANOKINE Trademark of Inzen Therapeutics, Inc. - Serial …
Web18 mei 2024 · Flagship Pioneering describes itself as a bioplatform innovation company whose focus is developing and launching cutting-edge companies. Its track record is … Web19 mrt. 2024 · He is a director and stockholder of Agios Pharmaceuticals and Editas Medicines and a founder and stockholder of Fate Therapeutics and Geruda Therapeutics. He is a consultant for FOG Pharma, Inzen Therapeutics, ResoluteBio and VCanBio and receives sponsored research support on an unrelated project from Sumitomo Dianippon. ev charging stations reedsport
Inzen Therapeutics Overview SignalHire Company Profile
WebWhere is Inzen Therapeutics 's headquarters? Inzen Therapeutics is located in New York, New York, United States. Who invested in Inzen … Web13 jan. 2024 · CAMBRIDGE, Mass., Jan. 13, 2024 /PRNewswire/ -- Flagship Pioneering, a life science platforms company, today announced the unveiling of Inzen Therapeutics. … WebINZEN: Last Applicant/Owner: Inzen Therapeutics, Inc. 55 Cambridge Parkway Suite 800e Cambridge, MA 02142 : Serial Number: 88052072: Filing Date: July 25, 2024: … ev charging stations rockhampton